Gene · 3675
Papers2,788
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,788
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Streamlining single-cell spatial transcriptomics for human kidney tissue. | Biotechniques | 2025 | 41324332 | PubTator, text mining | PubMed |
| The role of ITGA3 expression in predicting liver metastasis in patients with epithelial ovarian cancer. | BMC Med Genomics | 2025 | 41286938 | PubTator, text mining | PubMed |
| Expression of ITGA3 in pan-cancer tissues and its relationship to prognosis and immune infiltration. | Discov Oncol | 2025 | 41249748 | PubTator, text mining | PubMed |
| Photobiomodulation in fibroblasts: from light to healing through molecular pathways, omics and artificial intelligence. | Front Bioeng Biotechnol | 2025 | 41180838 | PubTator, text mining | PubMed |
| Extracellular matrix-driven metabolic control of pancreatic endocrine lineage allocation. | EMBO Rep | 2025 | 41145874 | PubTator, text mining | PubMed |
| Bioinformatics analysis to investigate the genetic associations between diabetes and pancreatic cancer. | Aging Male | 2025 | 41099341 | PubTator, text mining | PubMed |
| Rab3A attenuated H₂O₂-induced mitochondrial dysfunction and damage in HEI-OC1 cells by stabilizing ITGA3 expression. | J Bioenerg Biomembr | 2025 | 41085878 | PubTator, text mining | PubMed |
| Genomic and clinical characterization of adult CVID patients: results from a single-centre turkish cohort. | Immunol Res | 2025 | 41071379 | PubTator, text mining | PubMed |
| Inhibition of integrin α3 suppresses gastric cancer progression via STAT3-mediated regulation of SLC1A5-dependent glutamine uptake. | J Gastroenterol | 2025 | 41060436 | PubTator, text mining | PubMed |
| Perfluorooctanesulfonic acid facilitates the migration of choriocarcinoma cell line BeWo: Integrins as potential target. | Environ Pollut | 2025 | 41047067 | PubTator, text mining | PubMed |
| Oligomeric Proanthocyanidins Reverse Lenvatinib Resistance in Hepatocellular Carcinoma Through ITGA3-Mediated Pathway. | Pharmaceuticals (Basel) | 2025 | 41011230 | PubTator, text mining | PubMed |
| Phocaeicola plebeius oral treatment improve fibrosis by reversing cirrhosis-related hepatic gene dysregulation. | Life Sci | 2025 | 40992653 | PubTator, text mining | PubMed |
| A Chemical Glycoproteomic Approach Decrypts Urinary Extracellular Vesicle Surfaceome for Prostate Cancer Diagnosis and Grading. | Angew Chem Int Ed Engl | 2025 | 40985750 | PubTator, text mining | PubMed |
Measurement properties of instruments used to measure health-related quality of life in pediatric and adults patients with inherited epidermolysis bullosa: A systematic review and meta-analysis protocol. | PLoS One | 2025 | 40971360 | PubTator, text mining | PubMed |
| Spatial colocalization and molecular crosstalk of myofibroblastic CAFs and tumor cells shape lymph node metastasis in oral squamous cell carcinoma. | PLoS Genet | 2025 | 40906645 | PubTator, text mining | PubMed |
| Study on differentially expressed genes and pattern recognition receptors in osteoporosis based on bioinformatics analysis. | Sci Rep | 2025 | 40854963 | PubTator, text mining | PubMed |
| Ubiquitin-proteasome system dysregulation in FAM111B-related poikiloderma and phenotypic spectrum expansion: new case reports and long-term follow-up. | EBioMedicine | 2025 | 40840166 | PubTator, text mining | PubMed |
| RHOV is a Detachment-Responsive Rho GTPase Necessary for Ovarian Cancer Peritoneal Metastasis. | bioRxiv | 2025 | 40832333 | PubTator, text mining | PubMed |
| Multi-omics analysis and validation of autophagy-related diagnostic biomarker in osteoarthritis. | Ann Med | 2025 | 40828304 | PubTator, text mining | PubMed |
| Identification of foam cell like M2 macrophages, AEBP1 biomarkers, and resveratrol as potential therapeutic in MASLD using Ecotyper and WGCNA. | Sci Rep | 2025 | 40825823 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3675/papers?page=4